Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02903407 · ClinicalTrials.gov registry record · Phase 4
Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 7
- Enrollment target
NCT02903407: Clinical Trial Phase 4 study, sponsored by Duke University.
NCT02903407 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 7 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02903407, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 7 participants
- Enrollment target
Study Summary
This study aims to examine the use of protocol directed sedation using the Duke PAD protocol with the current sedation medications of propofol or dexmedetomidine compared to the PAD protocol with midazolam, per cardiac intensive care unit (CICU) usual care, as an initial step toward understanding the best management of sedation in these patients.
Primary Outcome
Number of days of admission to the CICU during the index hospitalization
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2019-06-30 |
| Phase | Phase 4 |
Why NCT02903407 stopped before completion
NCT02903407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Midazolam is the first listed.
NCT02903407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02903407 about?
NCT02903407 is a clinical study titled "Pain, Agitation and Delirium (PAD) Protocol in the Duke CICU". This study aims to examine the use of protocol directed sedation using the Duke PAD protocol with the current sedation medications of propofol or dexmedetomidine compared to the PAD protocol with midazolam, per cardiac intensive care unit (CICU) usual care, as an initial step toward understanding th...
What is the current status of trial NCT02903407?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 7 participants. The study started on 2017-09-01. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02903407?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT02903407?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02903407's enrollment target sits among peer trials
7 1981st of 2000 higher than 18 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI